1. A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence
   Marcia V. Fournier et al, 2019, Scientific Reports CrossRef
2. Machine Learning Frameworks to Predict Neoadjuvant Chemotherapy Response in Breast Cancer Using Clinical and Pathological Features
   Nicholas Meti et al, 2021, JCO Clinical Cancer Informatics CrossRef
3. Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy
   Jens Huober et al, 2023, npj Breast Cancer CrossRef
4. Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancer
   Yara Abdou et al, 2022, Scientific Reports CrossRef
5. Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
   Ayako Nakashoji et al, 2017, Oncology Letters CrossRef
6. Neoadjuvant chemotherapy for breast cancer: Pathologic response rates but not tumor size, has an independent prognostic impact on survival
   Gilles Houvenaeghel et al, 2024, Cancer Medicine CrossRef